New diabetes clinical trial: Effect of Insulin Lowering on Lipogenesis
Published on: February 10, 2026 at 11:00PM
Conditions: Hyperinsulinemia; Insulin Resistance; Non-Alcoholic Fatty Liver Disease; Prediabetic State; Obesity
Interventions: Drug: Placebo; Drug: Diazoxide Oral Suspension, 2 mg per kg per dose; Drug: Deuterated water (2H2O/D2O), 70%; Diagnostic Test: Insulin Suppression Test (IST)
Sponsors: Columbia University; University of California, Berkeley; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
https://ift.tt/xjP7hTV
Conditions: Hyperinsulinemia; Insulin Resistance; Non-Alcoholic Fatty Liver Disease; Prediabetic State; Obesity
Interventions: Drug: Placebo; Drug: Diazoxide Oral Suspension, 2 mg per kg per dose; Drug: Deuterated water (2H2O/D2O), 70%; Diagnostic Test: Insulin Suppression Test (IST)
Sponsors: Columbia University; University of California, Berkeley; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
https://ift.tt/xjP7hTV
Comments
Post a Comment